Lowe Brockenbrough & Co’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.24M Sell
26,270
-905
-3% -$80.7K 0.11% 119
2025
Q4
$2.15M Sell
27,175
-533
-2% -$41.8K 0.11% 124
2025
Q3
$2.21M Sell
27,708
-900
-3% -$76.8K 0.11% 120
2025
Q2
$2.6M Sell
28,608
-3
-0% -$274 0.15% 115
2025
Q1
$2.68M Buy
28,611
+3
+0% +$269 0.18% 112
2024
Q4
$2.6M Sell
28,608
-1,300
-4% -$124K 0.17% 114
2024
Q3
$3.1M Hold
29,908
0.2% 108
2024
Q2
$2.9M Hold
29,908
0.19% 105
2024
Q1
$2.69M Hold
29,908
0.18% 110
2023
Q4
$2.38M Sell
29,908
-50
-0.2% -$3.76K 0.18% 107
2023
Q3
$2.13M Sell
29,958
-250
-0.8% -$18.7K 0.17% 119
2023
Q2
$2.33M Sell
30,208
-126
-0.4% -$9.75K 0.18% 116
2023
Q1
$2.28M Buy
30,334
+266
+0.9% +$19.8K 0.18% 116
2022
Q4
$2.37M Hold
30,068
0.21% 110
2022
Q3
$2.11M Sell
30,068
-20
-0.1% -$1.57K 0.2% 114
2022
Q2
$2.41M Buy
30,088
+20
+0.1% +$1.56K 0.21% 109
2022
Q1
$2.28M Hold
30,068
0.17% 121
2021
Q4
$2.57M Hold
30,068
0.19% 108
2021
Q3
$2.27M Sell
30,068
-8,000
-21% -$635K 0.18% 121
2021
Q2
$3.1M Sell
38,068
-400
-1% -$32.7K 0.28% 87
2021
Q1
$3.03M Sell
38,468
-300
-0.8% -$23.5K 0.29% 87
2020
Q4
$3.31M Hold
38,768
0.36% 79
2020
Q3
$2.99M Sell
38,768
-851
-2% -$64.9K 0.37% 76
2020
Q2
$2.9M Hold
39,619
0.39% 72
2020
Q1
$2.63M Sell
39,619
-700
-2% -$49.4K 0.43% 69
2019
Q4
$2.78M Hold
40,319
0.34% 83
2019
Q3
$2.96M Sell
40,319
-738
-2% -$53.5K 0.4% 77
2019
Q2
$2.94M Hold
41,057
0.4% 73
2019
Q1
$2.81M Buy
41,057
+208
+0.5% +$13.4K 0.39% 77
2018
Q4
$2.43M Buy
40,849
+480
+1% +$30K 0.4% 76
2018
Q3
$2.7M Buy
40,369
+51
+0.1% +$3.4K 0.38% 75
2018
Q2
$2.61M Hold
40,318
0.38% 79
2018
Q1
$2.89M Sell
40,318
-50
-0.1% -$3.6K 0.43% 74
2017
Q4
$3.05M Hold
40,368
0.44% 72
2017
Q3
$2.94M Hold
40,368
0.45% 71
2017
Q2
$2.99M Sell
40,368
-142
-0.4% -$10.5K 0.47% 68
2017
Q1
$2.96M Hold
40,510
0.47% 68
2016
Q4
$2.65M Sell
40,510
-400
-1% -$27.4K 0.44% 71
2016
Q3
$3.03M Buy
40,910
+1,125
+3% +$83.2K 0.52% 65
2016
Q2
$2.91M Sell
39,785
-413
-1% -$29.4K 0.51% 68
2016
Q1
$2.84M Hold
40,198
0.49% 70
2015
Q4
$2.68M Sell
40,198
-5,990
-13% -$398K 0.46% 72
2015
Q3
$2.93M Sell
46,188
-100
-0.2% -$6.53K 0.51% 70
2015
Q2
$3.03M Sell
46,288
-5,000
-10% -$339K 0.49% 72
2015
Q1
$3.56M Sell
51,288
-4,100
-7% -$283K 0.56% 64
2014
Q4
$3.83M Sell
55,388
-47
-0.1% -$3.17K 0.61% 58
2014
Q3
$3.62M Sell
55,435
-9,800
-15% -$646K 0.58% 64
2014
Q2
$4.45M Sell
65,235
-200
-0.3% -$13.4K 0.71% 57
2014
Q1
$4.25M Sell
65,435
-4,700
-7% -$296K 0.71% 57
2013
Q4
$4.57M Sell
70,135
-1,000
-1% -$64K 0.76% 55
2013
Q3
$4.22M Sell
71,135
-4,965
-7% -$294K 0.77% 55
2013
Q2
$4.36M Buy
+76,100
New +$4.52M 0.81% 54

Other funds holding CL

Lowe Brockenbrough & Co's CL Position: Q1 2026 in Review

Lowe Brockenbrough & Co reduced its Colgate-Palmolive (CL) stake by 3.3% in Q1 2026, selling an estimated $80.7K and leaving 26,270 shares worth $2.24M. The position accounts for 0.11% of the portfolio, ranked #119.

Lowe Brockenbrough & Co first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.57M in Q4 2013. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Lowe Brockenbrough & Co held 26,270 shares of Colgate-Palmolive worth $2.24M as of Q1 2026.
  • Lowe Brockenbrough & Co sold 905 Colgate-Palmolive shares in Q1 2026, an estimated $80.7K.
  • Colgate-Palmolive made up 0.11% of Lowe Brockenbrough & Co's portfolio in Q1 2026, its #119 holding.
  • Lowe Brockenbrough & Co first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Lowe Brockenbrough & Co's Colgate-Palmolive position peaked at $4.57M in Q4 2013.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Lowe Brockenbrough & Co's 13F filing for Q1 2026, filed 7 May 2026.